Search
Select region
Close filter

Anna Vichniakova

Contact Details

+44 207 943 1956

Anna Vichniakova is based in London, working globally in Egon Zehnder’s Health Practice serving a broad range of clients from large pharmaceutical companies to earlier stage biotechs, as well as VC and PE investors. She leads executive and Board searches, management assessments, and development and leadership advisory mandates. Anna has a particular expertise in CEO, commercial and HR functions.

For me, my work is all about people. I tackle assignments with commitment and passion because I really want to see my clients succeed.

Anna came to Egon Zehnder after a career with Boston Consulting Group, where she was a Principal working in healthcare and technology. During her time at BCG she supported major pharmaceutical companies with post-merger integration and provided advice on strategy, operating models and organizational design, change management and client enablement in R&D, and both commercial and global functions. While at BCG Anna was also seconded to the World Economic Forum’s global health team in Geneva. Prior to BCG, she worked with Hewlett-Packard on corporate venturing and consulting projects and at Sportal, a sports-media content provider.

Anna earned a Bachelor of Laws (LLB) at Moscow International University, an MA in Liberal Arts at Dartmouth College and an MBA at Tuck School of Business at Dartmouth.

My Areas of Focus

Get in touch
Send Anna a Message
Browse all
Thought Leadership

Thought Leadership by Anna Vichniakova

EU Biotech CEOs and Board Members Reflect on a Turbulent 2020

EU Biotech CEOs and Board Members Reflect on a Turbulent 2020

Egon Zehnder rounded off 2020 with a final gathering of biotech CEOs and board members, who shared their reflections on a turbulent year. Read more

In for the Long Haul: Biotechs Address the Issues Presented by the Extended Pandemic

In for the Long Haul: Biotechs Address the Issues Presented by the Extended Pandemic

Evolving personal work patterns are demonstrating people’s amazing adaptability in the face of the pandemic. Read more

Biotech During a Pandemic: Addressing Challenges Along the Pharma Value Chain

Biotech During a Pandemic: Addressing Challenges Along the Pharma Value Chain

European Biotech leaders reveal to Egon Zehnder that people are becoming much more comfortable and efficient at using virtual meetings. Read more

European Biotech CEOs Navigate Towards a “New Normal

European Biotech CEOs Navigate Towards a “New Normal" Pt 2

Highlights from the fourth round of digital gatherings with European Biotech CEOs, hosted by Egon Zehnder. Read more

Coronavirus – Learnings and Takeaways from Small Biotech

Coronavirus – Learnings and Takeaways from Small Biotech

Highlights from the second round of digital gatherings with European Biotech CEOs, hosted by Egon Zehnder. Read more

European Biotech CEOs Navigate Towards a “New Normal” Pt 1

European Biotech CEOs Navigate Towards a “New Normal” Pt 1

Highlights from the third round of digital gatherings with European Biotech CEOs, hosted by Egon Zehnder. Read more

Discussions with European Biotechs—Bringing Purpose in a Time of Crisis

Discussions with European Biotechs—Bringing Purpose in a Time of Crisis

On April 8 and 9 Egon Zehnder virtually convened a number of biotech board directors to discuss some of the challenges being faced by… Read more

Related Experts Around the Globe

Bhawana Malhotra

Bhawana Malhotra

Singapore

Bhawana Malhotra, based in Singapore, has deep expertise in health care and guides clients in the health, consumer, and technology sectors. Read more

Marwa Zohdy

Marwa Zohdy

Chicago

Based in Chicago, Marwa Joy Zohdy is an active member of Egon Zehnder’s global Health Practice. Read more

Hilke Öry

Hilke Öry

Amsterdam

Hilke Öry, based in Amsterdam, leads Egon Zehnder’s Financial Services practice for The Netherlands. She is also a core member of Egon Zehnder’s… Read more

Changing language
Close icon

You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.

Continue to the website

Back to top